Fosamax Injury Attorney - Cohen & Malad, LLP

Merck Fosamax Bone Injury Lawyers


In 1995, the FDA approved the use of Fosamax to treat osteoporosis. Fosamax limits bone loss by inhibiting the breakdown of old or damaged bones. Since 2006, thousands of product liability lawsuits have been filed in state and federal courts against Merck, the maker of Fosamax. The most common injury caused by Fosamax is osteonecrosis of the jaw (ONJ). ONJ, also called jaw death, is a painful disease that can result in loosening of teeth, gum lesions, and infections or splintering of the jaw bone. ONJ appears to particularly affect Fosamax users who had dental surgery or treatment. Other serious side effects of Fosamax include: irritation, inflammation, or ulceration of the esophagus; severe bone, joint, or muscle pain; abnormal heart rhythm; and femur fractures and other problems with the bones in the hips, shoulders, and knees. In fact, in October 2010, the FDA mandated that femur fractures be added to the warnings and precautions section of the label on Fosamax and other similar medications.

If you or a loved one is experiencing any side effects after using Fosamax or another drug to treat osteoarthritis, pleaseĀ contact us to speak with one of our experienced product liability/personal injury attorneys at Cohen & Malad, LLP to discuss your legal options and help you seek the compensation you deserve.